Efficient synthesis of aminomethylated azaindoles and corresponding pyrrole-fused derivatives by copper-catalyzed domino multicomponent coupling and cyclization by Hou, Zengye et al.
Title
Efficient synthesis of aminomethylated azaindoles and
corresponding pyrrole-fused derivatives by copper-catalyzed
domino multicomponent coupling and cyclization
Author(s)Hou, Zengye; Suzuki, Yamato; Oishi, Shinya; Fujii, Nobutaka;Ohno, Hiroaki
CitationTetrahedron (2012), 68(6): 1695-1703
Issue Date2012-02
URL http://hdl.handle.net/2433/153295




Efficient synthesis of aminomethylated azaindoles and corresponding pyrrole-fused 
derivatives by copper-catalyzed domino multicomponent coupling and cyclization 
Zengye Hou, Yamato Suzuki, Shinya Oishi, Nobutaka Fujii ∗, Hiroaki Ohno * 
Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan 
 
 
∗ Corresponding author. E-mail addresses: nfujii@pharm.kyoto-u.ac.jp (N. Fujii), hohno@pharm.kyoto-u.ac.jp (H. Ohno). 
1. Introduction 
Azaindoles and related heteroaromatic ring systems are 
common scaffolds in biologically active natural and synthetic 
compounds. Their widespread application as pharmaceutical 
agents1–7 makes them attractive synthetic targets. Several 
synthetic routes to access azaindoles are described in the 
literature, most of which rely on linear synthesis utilizing the 
conventional cyclization of ortho-amino-alkynyl pyridines 
promoted by bases or transition metals.8–13 However, few 
methods have been reported for azaindole synthesis based on 
multiple component reactions, which provide a divergent 
approach to functionalized azaindoles in a single step.14–17 
We recently reported the direct synthesis of 2-
(aminomethyl)indoles 3 via copper-catalyzed domino three-
component coupling and cyclization reactions of ethynylaniline 1 
(Scheme 1).18–20 The mechanism of this reaction involves the 
formation of the propargylamine intermediate 2 by Mannich-type 
three-component coupling of 1 with paraformaldehyde and a 
secondary amine, and subsequent copper-catalyzed 
intramolecular cyclization. Using a modified protocol, we 
developed an efficient synthesis of a series of aminomethylated 
dipyrroloarenes by direct biscyclization.21  
As a part of our ongoing project directed toward development 
of novel CK2 inhibitors,22,23 we designed aminomethylated 
azaindole derivatives 4 and more complicated pyrrole-fused 
azaindole derivatives 5 as potential drug-like templates (Figure 1). 
They are considered to be synthesized by a copper-catalyzed 
three-component coupling and cyclization reaction. Here, we 
report our research on the synthesis of aminomethylated 
azaindole derivatives 4 using various aldehydes and secondary 
amines. The synthesis of corresponding pyrrole-fused derivatives 













Scheme 1. Copper-catalyzed domino three-component 




















Figure 1. Synthetic targets 4 and 5 as potential drug-like 
templates 
 
2. Results and discussion 
We initially designed a synthetic route to 4 and 5 through a 
common starting material 6 (Scheme 2). The azaindoles 4 
bearing an aminomethyl group can be directed from their nitro 
congener 7 by reduction. The nitroazaindole 7 is considered to be 
synthesized by the copper-catalyzed three-component coupling 
and cyclization reaction of 6 with various aldehydes and 
secondary amines. The amino group of 4 is envisioned to 
facilitate a regioselective ortho-bromination, permitting 
introduction of an alkynyl group by Sonogashira coupling. 
Finally, the subsequent intramolecular cyclization would afford 
the pyrrole-fused azaindoles 5. 
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Scheme 2. Initial strategy for the synthesis of 4 and 5 
 
In our previous study on three-component indole formation, 
the intramolecular hydroamination required N-substituted 
ethynylanilines.18,21 Therefore, 3-ethynyl-4-aminopyridine 6a 
having an acetyl group was synthesized (see Experimental 4.2) 
and applied to optimize the reaction conditions for the domino 
three-component coupling-cyclization (Table 1). We started our 
investigation by treating 6a with paraformaldehyde and 
dipropylamine in dioxane at 80 °C in the presence of 10 mol % 
of CuI (entry 1). The initial Mannich-type three-component 
coupling was found to proceed readily to afford 8a by TLC. 
However, the subsequent intramolecular hydroamination was 
rather slow to yield the desired cyclization product 7a as the 
deacetylated form in low yield (40%),26 accompanied by the 
formation of undesired bis-aminomethylated side product 9a in 
10% yield. Addition of K3PO4 resulted in decomposition of the 
substrate (entry 2), whereas Et3N slightly improved the yield of 
7a (49%, entry 3). According to the previous study, the 
counteranion of copper catalysts considerably affects the 
reactivity of the alkyne toward intramolecular 
hydroamination.18,21 Among the copper salts investigated (CuI, 
CuBr, CuCl, entries 3–5), CuCl afforded the highest yield of 7a 
(61%, entry 5). Considering that AcOH (resulted in situ from 6a 
by the deacetylation with water formed in the step of Mannich 
reaction) might hinder intramolecular hydroamination, we 
applied MS4A as an additive to remove water and/or AcOH. As 
hoped, addition of MS4A dramatically accelerated the cyclization 
rate to yield 7a in 85% yield without formation of the side 
product 9a (entry 6). Next, we examined the scope of the 2-
(aminomethyl)azaindole formation using several secondary 
amines (entries 7–10). All the secondary amines tested here 
proved to be acceptable as amine components to yield desired 
products 7b–7e in high yields (71–86%). 
We also investigated the three-component synthesis of 2-
(aminomethyl)azaindoles using alkyl or aryl aldehydes (Scheme 
3). Treating 6a with butanal and piperidine under optimized 
conditions afforded the three-component coupling intermediate 
10a without formation of the desired cyclization product 11a. 
Instead of Et3N, use of the relatively strong base DBU was 
effective in promoting the intramolecular hydroamination of 10a. 
After complete formation of 10a (monitored by TLC), DBU (2 
equiv) was added to the reaction mixture to give the desired 
azaindole 11a in 68% yield in a one-pot manner (eq 1). 
Meanwhile, treatment of 6a with benzaldehyde and piperidine 
under standard conditions afforded the three-component coupling 
intermediate 10b in 59% yield, mixed with an inseparable co-
product 12 in 18% yield. Although treatment of this mixture even 
after isolation with DBU was ineffective (leading to formation of 
undesired 1,6-naphthyridine 13 in 60% yield), replacement of 
DBU with K3PO4 as a base afforded the desired azaindole 11b in 
a moderate yield (56%, eq 2). Formation of the naphthyridine 13 
is attributable to isomerization of the alkyne 10b to the 
corresponding allene by the action of DBU followed by 6-endo 
cyclization and elimination of piperidine. 
Table 1. Synthesis of azaindole derivatives 7 using paraformaldehyde  
(HCHO)n (2 equiv), R2NH (1 equiv)
[Cu] (10 mol %)



















Entry [Cu] Base Additive R2NH Time (h) 
Yield % (product)a 
7 8 9
1 CuI – – (n-Pr)2NH 10 40 (7a) 20 (8a) 10 (9a) 
2 CuI K3PO4 – (n-Pr)2NH 2  decomp.  
3 CuI Et3N – (n-Pr)2NH 10 49 (7a) 17 (8a) 4 (9a) 
4 CuBr Et3N – (n-Pr)2NH 10 42 (7a) 10 (8a) trace (9a)
5 CuCl Et3N – (n-Pr)2NH 10 61 (7a) 13 (8a) 5 (9a) 
6 CuCl Et3N MS4A (n-Pr)2NH 2 85 (7a) trace (8a)  
7 CuCl Et3N MS4A piperidine 2 71 (7b)   
8 CuCl Et3N MS4A (i-Pr)2NH 1.5 81 (7c)   
9 CuCl Et3N MS4A Et2NH 2 73 (7d)   
10 CuCl Et3N MS4A diallylamine 1 86 (7e)   
aIsolated yields. 
n-PrCHO (2 equiv)
piperid ine (1 equiv)




























































K3PO4 (4.5 h)  
Scheme 3. Synthesis of azaindole derivatives 11 using n-
PrCHO or PhCHO 
 
With a series of azaindole derivatives 7 and 11 bearing a nitro 
group in hand, we tested the reduction of the nitro group and 
subsequent regioselective ortho-bromination (Scheme 4). 
Treatment of 7a with Pd/C under a H2 atmosphere enabled the 
reduction to afford 14 bearing an amino group. However, 
bromination of 14 with 1.0 equiv Br2 or NBS failed to yield the 
desired product 15, resulting in a mixture of mono- and bis-
brominated products with simultaneous decomposition of the 
substrate 14. 1H NMR indicated that the 3 position of the 
azaindole 14 prefers to undergo bromination rather than the 
position ortho to the amino group. Protection of the indole with a 
Ts or Boc group was unsuccessful. Faced with the difficulty of 
regioselective bromination and the instability of 14, we decided 





14 (R = H)






7a Br2 or NBS
(1 equiv)
3




Scheme 4. Unsuccessful ortho-bromination of 
aminoazaindole 14 
 
Considering the difficulty in introduction of an alkynyl group 
after formation of an azaindole framework, we designed a new 
route to access 5 from a 3,4-diaminopyridine derivative 16 
bearing two alkynyl groups (Scheme 5). We expected that 
regioselective introduction of an electron-withdrawing protecting 
group (Pg) would facilitate controlled monocyclization of 16 to 
produce azaindole 17. The three-component coupling-cyclization 























Scheme 5. Revised strategy for the synthesis of 
pyrroloazaindole 5  
 
We started our synthesis from commercially available 3,4-
diaminopyridine 18 (Scheme 6). Treating 18 with bromine in 
48% aqueous HBr afforded the desired bis-brominated product 
19.27 Sonogashira coupling of 19 with an excessive amount of 
trimethylsilylacetylene failed to introduce two alkynyl groups, 
instead yielding a mono-alkynylated product 20 in 80% yield. 
We expected that the nucleophilicity of the amino group of 20 at 
the 4 position would be lower than that on the 3 position owing 
to delocalization of the nitrogen non-bonding electron into the 
pyridine ring. As hoped, by treating 20 with 2 equiv of MsCl in 
pyridine in the presence of DMAP, regioselective bis-mesylation 
of the amino group at the 3 position proceeded readily to produce 
21 in 73% yield. Sonogashira coupling of 21 with 
trimethylsilylacetylene afforded the desired aminopyridine 
derivative 22 with two alkynyl groups. Introduction of electron-
withdrawing Ms groups would result in a decrease of electron 
density of the pyridine ring, facilitating a second Sonogashira 
coupling at the 5 position. Subsequent deprotection of TMS 
groups and one of the Ms groups produced 23, which underwent 
regioselective monocyclization in the presence of Et3N and CuI 
to yield 24 in 57% yield in two steps. Then, by use of standard 
methods for acetylation or mesylation, N-substituted amino 

















































95 ºC, 5 h
(45%)
PdCl2(PPh3)2, CuI, Et3N




















70 ºC, 1 h
(69%)
1) Ac2O, DMAP, Et3N, 70 ºC, 5 h
MsCl, NaH
2) K2CO3, MeOH, r t, 5 min
(25% from 24)
THF, –20 ºC to rt, 2 h
(53%)
 
Scheme 6. Synthesis of azaindole derivatives 25 and 26  
Three-component coupling and cyclization of 25 with 
paraformaldehyde and dipropylamine was first investigated under 
the condition optimized in Table 1 (Scheme 7). The Mannich-
type coupling product 28 was isolated without formation of the 
Tetrahedron 4 
desired cyclization product 27 even with a prolonged reaction 
time. In our previous study on three-component indole formation, 
the rate of hydroamination was significantly dependent upon the 
acidity of the proton on the nitrogen atom.18,21 In case of substrate 
6a (Scheme 3), a highly electron-withdrawing nitro group ortho 
to the amino group would contribute to an increase in the acidity 
of the acetamide proton, thereby facilitating hydroamination. The 
acidity of acetamide proton of 25 (Scheme 7) was considered to 









25 (R = H)





CuCl (10 mol %)




Scheme 7. Attempted synthesis of pyrroloazaindole derivative 
27 
 
We therefore tested three-component coupling and cyclization 
with more acidic methanesulfonamide 26 (Table 2). Treating 26 
with paraformaldehyde and dipropylamine at room temperature 
in the presence of 5 mol % of CuI afforded the desired 
pyrroloazaindole 29 in a low yield (30%) accompanied by 
generation of a considerable amount of the 2-unsubstituted 
pyrroloazaindole 30 (entry 1). Use of a mixed solvent of toluene 
and dioxane partially suppressed the undesired cyclization at the 
terminal alkyne before the Mannich-type reaction, resulting in a 
slightly improved yield of 29 (45%, entry 2). For accelerating the 
rate of the Mannich-type reaction, a mixture of paraformaldehyde 
and dipropylamine in toluene was heated at 80 °C for 5 min, then 
added to the mixture of 26 in dioxane. As hoped, the desired 
product 29 was isolated in an improved yield (70%) with only a 
trace amount of the undesired product 30 (entry 3). The 
pyrroloazaindole 29 is stable in a solid state, whereas it was 
found to readily undergo a ring cleavage reaction in CDCl3. After 
24 hours at room temperature, formation of a ring-cleavage 
product 31 (31/29 = 4:1) was detected by 1H NMR analysis 
(Scheme 8). 
 

























1 dioxane 30 29 
2 toluene/dioxane (1:1) 45 15 
3c toluene/dioxane (1:1) 70 trace 
a Reactions were carried out with (HCHO)n (2 equiv) and (n-Pr)2NH (1 
equiv) using CuI (5 mol %) in toluene at rt. b Isolated yields. c A solution of 
(HCHO)n and (n-Pr)2NH in toluene (heated at 80 °C for 5 min) was added to 

















Scheme 8. Ring-cleavage reaction of 29 in CDCl3  
 
For suppressing this undesired ring-cleavage reaction and 
undertaking further functionalization of the N-protected 
pyrroloazaindole 29, we tested the deprotection of Ms groups 
(Scheme 9). To our surprise, treating 29 with Cs2CO3 in MeOH 
at 70 °C afforded a mono-deprotected ring-cleavage product 32 
in 12% yield, together with the major product 33, which was 
considered to be generated from 32 by its recyclization. A 
plausible mechanism for the formation of 33 is shown in Scheme 
10. First, the carbanion 34 would be formed by deprotonation of 
the sulfonamide 32 derived from the ring cleavage reaction of 29. 
The subsequent 6-exo cyclization of 34 followed by an 











































34 (R = Ms or H)











Scheme 10. Plausible mechanism for the formation of 33  
 
Faced with the difficulty of the deprotection of Ms groups 
from 29, we decided to remove the Ms group of 26 on the pyrrole 
ring first (Scheme 11). The deprotection of 26 proceeded readily 
to give 36, which underwent three-component coupling and 
cyclization with paraformaldehyde and dipropylamine under the 
condition optimized in Table 2 to furnish the mono-deprotected 
pyrroloazaindole 37 in a slightly decreased yield (65%). To our 
delight, fully deprotected pyrroloazaindole 27 could be derived 
from 37 in 78% yield by treating with Cs2CO3 in MeOH. The 
azaindoles 37 and 27 can be applied to further functional-group 
modifications, including N-alkylation or N-acylation for 






























50 ºC, 3 h
55 ºC, 1 h
 
Scheme 11. Synthesis of deprotected pyrroloazaindole 
derivatives 37 and 27  
 
3. Conclusion 
We have developed efficient methodologies for the synthesis 
of aminomethylated azaindoles using copper-catalyzed three-
component coupling and cyclization. A series of secondary 
amines and aldehydes can be used in this reaction, indicating this 
reaction to be synthetically useful for the diversity-oriented 
synthesis of azaindoles and related compounds. Furthermore, the 
more complicated pyrrole-fused azaindoles were also synthesized 
by controlled stepwise cyclization. Further studies for the 
development of CK2 inhibitors utilizing these drug-like 
templates are in progress. 
4. Experimental 
4.1. General 
1H NMR spectra were recorded using a JEOL AL-500 
spectrometer at 500 MHz frequency. Chemical shifts are reported 
in δ (ppm) relative to Me4Si (in CDCl3 or DMSO-d6) as internal 
standard. 13C NMR spectra were recorded using a JEOL AL-500 
and referenced to the residual CDCl3 or DMSO-d6 signal. 1H 
NMR spectra are tabulated as follows: chemical shift, number of 
protons, multiplicity (b = broad, s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet, br s = broad singlet) and 
coupling constant(s). Melting points were measured by a hot 
stage melting points apparatus (uncorrected). Exact mass 
(HRMS) spectra were recorded on a JMS-HX/HX 110A mass 
spectrometer. All reagents and solvents were of commercial 
quality and used without further purification. 





























THF, 60 ºC, 2 h
AcOH, rt, 48 h pyr idine
DMF




0 ºC, 10 min
(71%)
 
4.2.1. 3-Bromo-5-nitropyridin-4-amine (39). To a stirred mixture 
of 38 (3.0 g, 21.6 mmol) and NaOAc (2.7 g, 32.4 mmol) in 
glacial AcOH (72 mL) was added dropwise a mixture of Br2 (3.8 
g, 23.8 mmol) in glacial AcOH (24 mL), then the mixture was 
stirred for 48 h at room temperature. The reaction was quenched 
with saturated aqueous Na2S2O3 (10 mL), then the solvent was 
removed under reduced pressure. The resulting yellow solid was 
collected by filtration and washed by water (50 mL), then dried 
under vacuum. The crude product was recrystallized from n-
hexane–EtOAc (3:1) to give 39 (3.2 g, 67% yield) as yellow 
crystals. 1H and 13C NMR data were in agreement with those 
previously reported.28 
4.2.2. N-(3-Bromo-5-nitropyridin-4-yl)acetamide (40). To a 
stirred mixture of 39 (2.0 g, 9.2 mmol) and DMAP (113 mg, 0.92 
mmol) in DMF (10 mL) were added pyridine (3.7 mL, 46 mmol) 
and acetic anhydride (4.3 mL, 46 mmol), and the mixture was 
stirred for 2 h at 100 °C. After being cooled to room temperature, 
the resulting black mixture was filtered through a pad of Celite. 
The filtrate was concentrated under reduced pressure and the 
residue was purified by column chromatography over silica gel 
with n-hexane–EtOAc (2:1), then recrystallized from n-hexane–
EtOAc (3:1) to give 40 (1.1 g, 46% yield) as colorless crystals: Rf 
= 0.50 (silica gel, n-hexane/EtOAc = 1/1); mp 197 °C; IR (neat) 
cm-1 1681 (C=O), 1487 (NO2); 1H NMR (500 MHz, DMSO-d6) 
δ: 2.15 (3H, s), 9.02 (1H, s), 9.09 (1H, s), 10.64 (1H, br s); 13C 
NMR (125 MHz, DMSO-d6) δ: 22.8 (q), 117.5 (s), 136.7 (s), 
142.0 (s), 144.7 (d), 155.9 (d), 168.8 (s). Anal. Calcd for 
C7H6N3BrO3: C, 32.33; H, 2.33; N, 16.16; O, 18.46. Found: C, 
32.30; H, 2.22; N, 16.12; O, 18.56. 
4.2.3. N-{3-Nitro-5-[(trimethylsilyl)ethynyl]pyridin-4-
yl}acetamide (41). A mixture of 40 (500 mg, 1.9 mmol), 
trimethylsilylacetylene (0.4 mL, 2.8 mmol), CuI (19 mg, 0.1 
mmol), PdCl2(PPh3)2 (70 mg, 0.1 mmol), and Et3N (1 mL) in 
THF (10 mL) was stirred at 60 °C for 2 h under argon. After 
being cooled to room temperature, the mixture was filtered 
through a pad of Celite. The filtrate was concentrated under 
reduced pressure and the residue was purified by column 
chromatography over silica gel with n-hexane–EtOAc (3:1), then 
recrystallized from n-hexane–EtOAc (5:1) to give 41 (348 mg, 
65% yield) as brown crystals: Rf = 0.65 (silica gel, n-
hexane/EtOAc = 2/1); mp 135 °C; IR (neat) cm-1 2157 (C≡C), 
1726 (C=O), 1492 (NO2); 1H NMR (500 MHz, CDCl3) δ: 0.32 
(9H, s), 2.27 (3H, s), 8.21 (1H, br s), 8.76 (1H, s), 8.97 (1H, s); 
13C NMR (125 MHz, CDCl3) δ: 0.0 (3C, q), 24.2 (q), 95.7 (s), 
108.8 (s), 115.0 (s), 138.6 (s), 139.4 (s), 145.7 (d), 156.2 (d), 
167.7 (s). Anal. Calcd for C12H15N3O3Si: C, 51.97; H, 5.45; N, 
15.15. Found: C, 51.77; H, 5.48; N, 15.14. 
4.2.4. N-(3-Ethynyl-5-nitropyridin-4-yl)acetamide (6a). To a 
stirred mixture of 41 (300 mg, 1.1 mmol) in THF (5 mL) was 
added TBAF (1.0 M in THF, 1.2 mL, 1.2 mmol) under argon, 
and the mixture was stirred for 10 min at 0 °C. The mixture was 
quenched with saturated aqueous NH4Cl (1 mL) and extracted 
with EtOAc. The organic layer was washed with water and brine, 
dried over MgSO4, and evaporated. The residue was purified by 
column chromatography over silica gel with n-hexane–EtOAc 
(2:1), then recrystallized from n-hexane–EtOAc (3:1) to give 6a 
(158 mg, 71% yield) as brown crystals: Rf = 0.25 (silica gel, n-
hexane/EtOAc = 2/1); mp 190 °C (decomp.); IR (neat) cm-1 3271 
(C≡C), 1694 (C=O), 1484 (NO2); 1H NMR (500 MHz, DMSO-
d6) δ: 2.14 (3H, s), 4.94 (1H, s), 8.94 (1H, s), 9.01 (1H, s), 10.71 
(1H, s); 13C NMR (125 MHz, DMSO-d6) δ: 22.8 (q), 75.5 (s), 
91.1 (d), 115.0 (s), 138.8 (s), 140.7 (s), 145.3 (d), 156.9 (d), 
168.9 (s). Anal. Calcd for C9H7N3O3: C, 52.69; H, 3.44; N, 20.48; 
O, 23.39. Found: C, 52.65; H, 3.27; N, 20.43; O, 23.59. 
4.3. Copper-catalyzed three-component coupling and 
cyclization of 6a with various aldehydes and secondary 
amines 
4.3.1. General procedure for the synthesis of 7 using 
paraformaldehyde: synthesis of N-[(7-nitro-1H-pyrrolo[3,2-
c]pyridin-2-yl)methyl]-N-propylpropan-1-amine (7a) (Table 1, 
entry 6). To a stirred mixture of 6a (30 mg, 0.15 mmol), 
paraformaldehyde (9 mg, 0.29 mmol), CuCl (1.5 mg, 0.015 
Tetrahedron 6 
mmol), Et3N (0.04 mL, 0.29 mmol) and MS4A (73 mg) in 
dioxane (1.5 mL) was added dipropylamine (0.02 mL, 0.15 
mmol), and the mixture was stirred for 2.5 h at 80 °C under argon. 
After being cooled to room temperature, the mixture was filtered 
through a pad of Celite. The filtrate was concentrated under 
reduced pressure and the residue was purified by column 
chromatography over alumina with n-hexane–EtOAc (5:1) to 
give 7a (34 mg, 85% yield) as a yellow solid: Rf = 0.60 (alumina, 
n-hexane/EtOAc = 3/1); mp 123 °C; IR (neat) cm-1 1510 (NO2); 
1H NMR (500 MHz, CDCl3) δ: 0.91 (6H, t, J = 7.4 Hz), 1.48-1.55 
(4H, m), 2.45-2.48 (4H, m), 3.81 (2H, s), 6.56 (1H, s), 8.99 (1H, 
s), 9.16 (1H, s), 10.19 (1H, br s); 13C NMR (125 MHz, CDCl3) δ: 
11.8 (2C, q), 20.1 (2C, t), 51.6 (t), 56.2 (2C, t), 100.0 (d), 128.8 
(s), 130.2 (s), 132.4 (s), 137.8 (d), 142.8 (s), 147.5 (d); HRMS 
(FAB) calcd for C14H21N4O2 [M+H+]: 277.1664, found: 277.1660. 
4.3.2. 7-Nitro-2-(piperidin-1-ylmethyl)-1H-pyrrolo[3,2-
c]pyridine (7b) (Table 1, entry 7). By a procedure identical with 
that described for the preparation of 7a, 6a (30 mg, 0.15 mmol) 
was converted into 7b (27 mg, 71%) by the reaction with 
paraformaldehyde (9 mg, 0.29 mmol), CuCl (1.5 mg, 0.015 
mmol), Et3N (0.04 mL, 0.29 mmol) and piperidine (0.015 mL, 
0.15 mmol): yellow solid; Rf = 0.70 (alumina, n-hexane/EtOAc = 
3/1); mp 174 °C; IR (neat) cm-1 1514 (NO2); 1H NMR (500 MHz, 
CDCl3) δ: 1.48-1.49 (2H, m), 1.60-1.64 (4H, m), 2.42-2.46 (4H, 
m), 3.68 (2H, s), 6.58 (1H, s), 9.00 (1H, s), 9.18 (1H, s), 10.29 
(1H, br s); 13C NMR (125 MHz, CDCl3) δ: 24.1 (t), 25.9 (2C, t), 
54.8 (2C, t), 55.9 (t), 101.3 (d), 128.5 (s), 130.3 (s), 132.9 (s), 
138.1 (d), 141.2 (s), 147.6 (d); HRMS (FAB) calcd for 
C13H17N4O2 [M+H+]: 261.1351, found: 261.1343. 
4.3.3. N-Isopropyl-N-[(7-nitro-1H-pyrrolo[3,2-c]pyridin-2-
yl)methyl]propan-2-amine (7c) (Table 1, entry 8). By a procedure 
identical with that described for the preparation of 7a, 6a (30 mg, 
0.15 mmol) was converted into 7c (33 mg, 81%) by the reaction 
with paraformaldehyde (9 mg, 0.29 mmol), CuCl (1.5 mg, 0.015 
mmol), Et3N (0.04 mL, 0.29 mmol) and diisopropylamine (0.021 
mL, 0.15 mmol): yellow solid; Rf = 0.65 (alumina, n-
hexane/EtOAc = 3/1); mp 141 °C; IR (neat) cm-1 1523 (NO2); 1H 
NMR (500 MHz, CDCl3) δ: 1.09 (12H, d, J = 6.3 Hz), 3.05-3.13 
(2H, m), 3.89 (2H, s), 6.53 (1H, s), 8.97 (1H, s), 9.14 (1H, s), 
10.20 (1H, br s); 13C NMR (125 MHz, CDCl3) δ: 20.7 (4C, q), 
42.3 (t), 49.0 (2C, d), 98.6 (d), 129.3 (s), 132.0 (s), 137.5 (d), 
139.1 (s), 145.1 (s), 147.2 (d); HRMS (FAB) calcd for 
C14H21N4O2 [M+H+]: 277.1664, found: 277.1666. 
4.3.4. N-Ethyl-N-[(7-nitro-1H-pyrrolo[3,2-c]pyridin-2-
yl)methyl]ethan-1-amine (7d) (Table 1, entry 9). By a procedure 
identical with that described for the preparation of 7a, 6a (30 mg, 
0.15 mmol) was converted into 7d (27 mg, 73%) by the reaction 
with paraformaldehyde (9 mg, 0.29 mmol), CuCl (1.5 mg, 0.015 
mmol), Et3N (0.04 mL, 0.29 mmol) and diethylamine (0.017 mL, 
0.15 mmol): yellow solid; Rf = 0.70 (alumina, n-hexane/EtOAc = 
3/1); mp 98 °C; IR (neat) cm-1 1523 (NO2); 1H NMR (500 MHz, 
CDCl3) δ: 1.08 (6H, t, J = 7.2 Hz), 2.60 (4H, q, J = 7.2 Hz), 3.81 
(2H, s), 6.57 (1H, s), 8.99 (1H, s), 9.17 (1H, s), 10.22 (1H, br s); 
13C NMR (125 MHz, CDCl3) δ: 11.7 (2C, q), 47.2 (t), 50.5 (2C, t), 
100.4 (d), 128.7 (s), 130.9 (s), 132.6 (s), 138.0 (d), 142.5 (s), 
147.5 (d); HRMS (FAB) calcd for C12H17N4O2 [M+H+]: 249.1352, 
found: 249.1353.  
4.3.5. N-Allyl-N-[(7-nitro-1H-pyrrolo[3,2-c]pyridin-2-
yl)methyl]prop-2-en-1-amine (7e) (Table 1, entry 10). By a 
procedure identical with that described for the preparation of 7a, 
6a (30 mg, 0.15 mmol) was converted into 7e (34 mg, 86%) by 
the reaction with paraformaldehyde (9 mg, 0.29 mmol), CuCl 
(1.5 mg, 0.015 mmol), Et3N (0.04 mL, 0.29 mmol) and 
diallylamine (0.018 mL, 0.15 mmol): yellow solid; Rf = 0.65 
(alumina, n-hexane/EtOAc = 3/1); mp 131 °C; IR (neat) cm-1 
1522 (NO2); 1H NMR (500 MHz, CDCl3) δ: 3.16 (4H, d, J = 6.3 
Hz), 3.83 (2H, s), 5.21-5.26 (4H, m), 5.85-5.94 (2H, m), 6.58 (1H, 
s), 9.00 (1H, s), 9.17 (1H, s), 10.15 (1H, br s); 13C NMR (125 
MHz, CDCl3) δ: 49.9 (t), 56.7 (2C, t), 101.1 (d), 118.5 (2C, t), 
128.5 (s), 130.2 (s), 132.7 (s), 134.7 (2C, d), 138.0 (d), 141.5 (s), 
147.6 (d); HRMS (FAB) calcd for C14H17N4O2 [M+H+]: 273.1352, 
found: 273.1348. 
4.3.6. N-{3-[3-(Dipropylamino)prop-1-ynyl]-5-nitropyridin-4-
yl}acetamide (8a) and N,N'-(7-nitro-1H-pyrrolo[3,2-c]pyridine-
2,3-diyl)bis(methylene)bis(N-propylpropan-1-amine) (9a) (Table 
1, entry 1). To a stirred mixture of 6a (50 mg, 0.24 mmol), 
paraformaldehyde (15 mg, 0.48 mmol) and CuI (4.6 mg, 0.024 
mmol) in dioxane (2.0 mL) was added dipropylamine (0.033 mL, 
0.24 mmol), then the mixture was stirred for 10 h at 80 °C under 
argon. After being cooled to room temperature, the mixture was 
filtered through a pad of Celite. The filtrate was concentrated 
under reduced pressure and the residue was purified by column 
chromatography over alumina with n-hexane–EtOAc (10:1) to 
give 7a (26 mg, 40% yield), 8a (15 mg, 20% yield) and 9a (9 mg, 
10% yield). 
Compound 8a: light yellow solid; Rf = 0.25 (alumina, n-
hexane/EtOAc = 3/1); mp 151 °C; IR (neat) cm-1 2217 (C≡C), 
1683 (C=O), 1496 (NO2); 1H NMR (500 MHz, CDCl3) δ: 0.94 
(6H, t, J = 7.2 Hz), 1.50-1.57 (4H, m), 2.27 (3H, s), 2.50 (4H, t, J 
= 7.4 Hz), 3.72 (2H, s), 8.24 (1H, br s), 8.76 (1H, s), 8.97 (1H, s); 
13C NMR (125 MHz, CDCl3) δ: 11.8 (2C, q), 20.7 (2C, t), 23.9 
(q), 42.9 (t), 56.0 (2C, t), 76.2 (s), 97.6 (s), 114.9 (s), 137.8 (s), 
139.2 (s), 144.9 (d), 156.1 (d), 167.4 (s); HRMS (FAB) calcd for 
C16H23N4O3 [M+H+]: 319.1770, found: 319.1771. 
Compound 9a: yellow oil; Rf = 0.75 (alumina, n-hexane/EtOAc = 
3/1); IR (neat) cm-1 1520 (NO2); 1H NMR (500 MHz, CDCl3) δ: 
0.83 (6H, t, J = 7.4 Hz), 0.91 (6H, t, J = 7.4 Hz), 1.46-1.55 (8H, 
m), 2.35 (4H, t, J = 7.4 Hz), 2.45 (4H, t, J = 7.4 Hz), 3.68 (2H, s), 
3.77 (2H, s), 9.16 (1H, s), 9.24 (1H, s), 10.09 (1H, br s); 13C 
NMR (125 MHz, CDCl3) δ: 11.8 (2C, q), 12.0 (2C, q), 20.18 (2C, 
t), 20.20 (2C, t), 48.5 (t), 49.9 (t), 55.9 (2C, t), 56.4 (2C, t), 112.0 
(s), 129.3 (s), 130.0 (s), 132.0 (s), 137.9 (d), 139.3 (s), 147.8 (d); 
HRMS (FAB) calcd for C21H36N5O2 [M+H+]: 390.2869, found: 
390.2863. 
4.3.7. 7-Nitro-2-[1-(piperidin-1-yl)butyl]-1H-pyrrolo[3,2-
c]pyridine (11a). A mixture of 6a (60 mg, 0.29 mmol), butanal 
(0.055 mL, 0.58 mmol), piperidine (0.035 mL, 0.35 mmol) and 
CuCl (3 mg, 0.03 mmol) in dioxane (2 mL) was stirred at 80 °C 
for 15 min under argon. After Mannich-type three-component 
coupling was completed (monitored by TLC), DBU (0.09 mL, 
0.58 mmol) was added. The resulting mixture was stirred for 
additional 30 min at 80 °C under argon. After being cooled to 
room temperature, the mixture was filtered through a pad of 
Celite. The filtrate was concentrated under reduced pressure and 
the residue was purified by column chromatography over 
alumina with n-hexane–EtOAc (4:1) to give 11a (58 mg, 68% 
yield) as an orange oil; Rf = 0.75 (alumina, n-hexane/EtOAc = 
3/2); IR (neat) cm-1 1523 (NO2); 1H NMR (500 MHz, CDCl3) δ: 
0.94 (3H, t, J = 7.4 Hz), 1.28-1.44 (4H, m), 1.54-1.59 (4H, m), 
1.70-1.78 (1H, m), 1.90-1.97 (1H, m), 2.42-2.49 (4H, m), 3.66 
(1H, dd, J = 8.9, 4.9 Hz), 6.54 (1H, s), 8.99 (1H, s), 9.15 (1H, s), 
10.15 (1H, br s); 13C NMR (125 MHz, CDCl3) δ: 14.1 (q), 20.4 
(t), 24.5 (t), 26.3 (2C, t), 31.9 (t), 51.0 (2C, t), 63.1 (d), 100.8 (d), 
128.4 (s), 130.2 (s), 132.4 (s), 137.9 (d), 144.9 (s), 147.5 (d); 
HRMS (FAB) calcd for C16H23N4O2 [M+H+]: 303.1821, found: 
303.1818. 
4.3.8. 7-Nitro-2-[phenyl(piperidin-1-yl)methyl]-1H-pyrrolo[3,2-
c]pyridine (11b). A mixture of 6a (50 mg, 0.24 mmol), 
benzaldehyde (0.05 mL, 0.49 mmol), piperidine (0.025 mL, 0.24 
mmol) and CuCl (2.4 mg, 0.024 mmol) in dioxane (2 mL) was 
stirred at 80 °C for 30 min under argon. After being cooled to 
room temperature, solvent was removed under reduced pressure 
and the residue was purified by column chromatography over 
alumina with n-hexane–EtOAc (3:1) to give a mixture of 10b (54 
mg, 59% yield) and 12 (7 mg, 18% yield). To this mixture were 
added CuCl (1.5 mg, 0.015 mmol), K3PO4 (62 mg, 0.29 mmol) 
and dioxane (2 mL), then the mixture was stirred at 80 °C for 4.5 
h under argon. After being cooled to room temperature, the 
mixture was filtered through a pad of Celite. The filtrate was 
concentrated under reduced pressure and the residue was purified 
by column chromatography over alumina with n-hexane–EtOAc 
(5:1) to give 11b (28 mg, 56% yield from 10b) as a brown oil; Rf 
= 0.80 (alumina, n-hexane/EtOAc = 1/1); IR (neat) cm-1 1522 
(NO2); 1H NMR (500 MHz, CDCl3) δ: 1.43-1.45 (2H, m), 1.63-
1.64 (4H, m), 2.36-2.42 (4H, m), 4.77 (1H, s), 6.51 (1H, s), 7.33-
7.40 (5H, m), 8.95 (1H, s), 9.17 (1H, s), 10.26 (1H, br s); 13C 
NMR (125 MHz, CDCl3) δ: 24.3 (t), 26.2 (2C, t), 52.1 (2C, t), 
69.2 (d), 101.5 (d), 128.2 (d), 128.5 (s), 128.6 (2C, d), 128.8 (2C, 
d), 130.3 (s), 132.7 (s), 136.9 (s), 138.1 (d), 144.4 (s), 147.7 (d); 
HRMS (FAB) calcd for C19H21N4O2 [M+H+]: 337.1665, found: 
337.1663. 
4.3.9. 8-Nitro-2-phenyl-1,6-naphthyridine (13). By a procedure 
identical with that described for the preparation of 11b, 6a (50 
mg, 0.24 mmol) was converted into 10b (54 mg, 59%) mixed 
with 12 (7 mg, 18% yield) by the reaction with benzaldehyde 
(0.05 mL, 0.49 mmol), CuCl (2.4 mg, 0.024 mmol) and 
piperidine (0.025 mL, 0.24 mmol). To this mixture were added 
CuCl (1.5 mg, 0.015 mmol), DBU (0.043 mL, 0.29 mmol) and 
dioxane (2 mL), then the mixture was stirred at 80 °C for 30 min 
under argon. After being cooled to room temperature, solvent 
was removed and the residue was purified by column 
chromatography over alumina with n-hexane–EtOAc (5:1) to 
give 13 (21 mg, 60% yield from 10b) as a brown solid; Rf = 0.60 
(alumina, n-hexane/EtOAc = 1/1); mp 186 °C (decomp.); IR 
(neat) cm-1 1521 (NO2); 1H NMR (500 MHz, CDCl3) δ: 7.53-7.56 
(3H, m), 8.18 (1H, d, J = 8.7 Hz), 8.26-8.27 (2H, m), 8.45 (1H, d, 
J = 8.7 Hz), 9.13 (1H, s), 9.39 (1H, s); 13C NMR (125 MHz, 
CDCl3) δ: 121.4 (d), 123.2 (s), 128.3 (2C, d), 129.2 (2C, d), 
131.5 (d), 136.3 (d), 137.1 (s), 138.5 (s), 141.7 (d), 142.2 (s), 
155.8 (d), 163.2 (s); HRMS (FAB) calcd for C14H10N3O2 
[M+H+]: 252.0773, found: 252.0772. 
4.3.10. 2-[(Dipropylamino)methyl]-1H-pyrrolo[3,2-c]pyridin-7-
amine (14). A mixture of 7a (50 mg, 0.18 mmol) and 10% Pd/C 
(5 mg) in MeOH (2 mL) was stirred at room temperature for 1 h 
under H2 atmosphere. Then, the mixture was filtered through a 
pad of Celite. The filtrate was concentrated under reduced 
pressure and the residue was purified by column chromatography 
over alumina with CHCl3–MeOH (30:1) to give 14 (38 mg, 85% 
yield) as a brown oil: Rf = 0.50 (alumina, CHCl3/MeOH = 10/1); 
IR (neat) cm-1 3400, 3190 (NH × 2); 1H NMR (500 MHz, 
DMSO-d6) δ: 0.83 (6H, t, J = 7.2 Hz), 1.41-1.49 (4H, m), 2.38 
(4H, t, J = 7.4 Hz), 3.67 (2H, s), 5.16 (2H, br s), 6.26 (1H, s), 
7.51 (1H, s), 8.04 (1H, s), 10.71 (1H, s); 13C NMR (125 MHz, 
DMSO-d6) δ: 11.8 (2C, q), 19.5 (2C, t), 51.3 (t), 55.4 (2C, t), 
99.4 (d), 124.6 (d), 125.2 (s), 128.9 (s), 129.8 (s), 131.4 (d), 
137.5 (s); HRMS (FAB) calcd for C14H23N4 [M+H+]: 247.1923, 
found: 247.1922. 
4.4. Synthesis of pyrrole-fused azaindoles 
The compound 19 was prepared from commercially available 
3,4-diaminopyridine 18 according to a reported literature.27 
4.4.1. 5-Bromo-2-[(trimethylsilyl)ethynyl]pyridine-3,4-diamine 
(20). A mixture of 19 (3 g, 11.3 mmol), trimethylsilylacetylene 
(1.76 mL, 12.5 mmol), CuI (108 mg, 0.57 mmol), PdCl2(PPh3)2 
(398 mg, 0.57 mmol), and Et3N (8 mL) in dioxane (30 mL) was 
stirred at 70 °C for 1 h under argon. After being cooled to room 
temperature, the mixture was filtered through a pad of Celite. The 
filtrate was concentrated under reduced pressure and the residue 
was purified by column chromatography over silica gel with n-
hexane–EtOAc (5:1), then recrystallized from n-hexane–EtOAc 
(10:1) to give 20 (2.56 g, 80% yield) as light yellow crystals: Rf = 
0.55 (silica gel, n-hexane/EtOAc = 1/1); mp 185 °C; IR (neat) 
cm-1 3446, 3355, 3272, 3204 (NH × 4), 2144 (C≡C); 1H NMR 
(500 MHz, CDCl3) δ: 0.27 (9H, s), 3.93 (2H, br s), 4.46 (2H, br 
s), 8.00 (1H, s); 13C NMR (125 MHz, CDCl3) δ: 0.0 (3C, q), 
100.3 (s), 101.1 (s), 106.9 (s), 127.8 (s), 133.2 (s), 139.9 (s), 
143.0 (d). Anal. Calcd for C10H14N3BrSi: C, 42.26; H, 4.96; N, 
14.78; Br, 28.11. Found: C, 42.04; H, 4.92; N, 14.81; Br, 28.02. 
4.4.2. N-{4-Amino-5-bromo-2-[(trimethylsilyl)ethynyl]pyridin-
3-yl}-N-(methylsulfonyl)methanesulfonamide (21). To a stirred 
mixture of 20 (2.24 g, 7.9 mmol) and DMAP (98 mg, 0.8 mmol) 
in pyridine (10 mL) was added MsCl (3 mL, 40 mmol) at 0 °C, 
then the mixture was stirred at room temperature for 12 h under 
argon. To the resulting mixture was added water (20 mL) and 
extracted with EtOAc (50 mL). The organic layer was washed 
with brine, dried over MgSO4, and evaporated. The residue was 
purified by column chromatography over silica gel with n-
hexane–EtOAc (3:1), then recrystallized from n-hexane–EtOAc 
(5:1) to give 21 (2.53 g, 73% yield) as yellow crystals: Rf = 0.60 
(silica gel, n-hexane/EtOAc = 1/1); mp 208 °C (decomp.); IR 
(neat) cm-1 3477, 3385 (NH × 2), 2164 (C≡C), 1366, 1156 (SO2); 
1H NMR (500 MHz, CDCl3) δ: 0.26 (9H, s), 3.56 (6H, s), 5.04 
(2H, br s), 8.39 (1H, s); 13C NMR (125 MHz, CDCl3) δ: 0.0 (3C, 
q), 45.8 (2C, q), 101.5 (s), 102.2 (s), 108.4 (s), 119.5 (s), 144.3 
(s), 151.2 (s), 152.4 (d); HRMS (FAB) calcd for 
C12H19N3BrO2S2Si [M+H+]: 439.9770, found: 439.9764. 
4.4.3. N-{4-Amino-2,5-bis[(trimethylsilyl)ethynyl]pyridin-3-yl}-
N-(methylsulfonyl)methanesulfonamide (22). A mixture of 21 (1 
g, 2.3 mmol), trimethylsilylacetylene (0.5 mL, 3.5 mmol), CuI 
(44 mg, 0.23 mmol), PdCl2(PPh3)2 (161 mg, 0.23 mmol), and 
Et3N (4 mL) in dioxane (15 mL) was stirred at 70 °C for 4 h 
under argon. After being cooled to room temperature, the mixture 
was filtered through a pad of Celite. The filtrate was concentrated 
under reduced pressure and the residue was purified by column 
chromatography over silica gel with n-hexane–EtOAc (5:1), then 
recrystallized from n-hexane–EtOAc (10:1) to give 22 (758 mg, 
72% yield) as a white solid: Rf = 0.70 (silica gel, n-
hexane/EtOAc = 2/1); mp 193 °C; IR (neat) cm-1 3467, 3312 (NH 
× 2), 2141 (C≡C), 1369, 1164 (SO2); 1H NMR (500 MHz, 
DMSO-d6) δ: 0.21 (9H, s), 0.26 (9H, s), 3.60 (6H, s), 6.21 (2H, s), 
8.18 (1H, s); 13C NMR (125 MHz, DMSO-d6) δ: 0.0 (3C, q), 0.5 
(3C, q), 46.2 (2C, q), 98.1 (s), 101.3 (s), 102.9 (s), 105.8 (s), 
106.0 (s), 118.1 (s), 144.1 (s), 153.2 (d), 154.2 (s). Anal. Calcd 
for C17H27N3O4S2Si2: C, 44.61; H, 5.95. Found: C, 44.21; H, 5.70. 
4.4.4. N-(4-Amino-2,5-diethynylpyridin-3-yl)methanesulfonamide 
(23). To a stirred mixture of 22 (500 mg, 1.1 mmol) in MeOH 
(10 mL) was added K2CO3 (453 mg, 3.3 mmol) at 0 °C, then the 
mixture was stirred at room temperature for 30 min under argon. 
The mixture was filtered through a pad of Celite. The filtrate was 
concentrated under reduced pressure and the residue was purified 
by column chromatography over silica gel with CHCl3–MeOH 
(9:1) to give 23 (215 mg, 83% yield) as a white solid: Rf = 0.30 
(silica gel, CHCl3/MeOH = 9/1); mp 172 °C; IR (neat) cm-1 3488, 
3387, 3165 (NH × 3), 2100 (C≡C), 1318, 1152 (SO2); 1H NMR 
(500 MHz, DMSO-d6) δ: 3.10 (3H, s), 4.47 (1H, s), 4.69 (1H, s), 
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6.16 (2H, s), 8.11 (1H, s), 9.21 (1H, s); 13C NMR (125 MHz, 
DMSO-d6) δ: 42.2 (q), 77.0 (d), 81.5 (d), 84.7 (s), 89.6 (s), 103.6 
(s), 119.2 (s), 141.2 (s), 151.0 (d), 153.3 (s); HRMS (FAB) calcd 
for C10H10N3O2S [M+H+]: 236.0494, found: 236.0500. 
4.4.5. 6-Ethynyl-1-(methylsulfonyl)-1H-pyrrolo[3,2-b]pyridin-7-
amine (24). A mixture of 23 (1 g, 4.3 mmol), CuI (43 mg, 0.22 
mmol) and Et3N (0.6 mL, 4.3 mmol) in dioxane (10 mL) was 
stirred at 60 °C for 1 h under argon. After being cooled to room 
temperature, the mixture was filtered through a pad of Celite. The 
filtrate was concentrated under reduced pressure and the residue 
was purified by column chromatography over alumina with n-
hexane–EtOAc (2:1), then recrystallized from n-hexane–EtOAc 
(5:1) to give 24 (690 mg, 69% yield) as colorless crystals: Rf = 
0.55 (alumina, n-hexane/EtOAc = 1/1); mp 147 °C; IR (neat) cm-
1 3377, 3336 (NH × 2), 2094 (C≡C), 1352, 1113 (SO2); 1H NMR 
(500 MHz, CDCl3) δ: 3.21 (3H, s), 3.57 (1H, s), 6.10 (2H, s), 
6.82 (1H, d, J = 4.6 Hz), 7.66 (1H, d, J = 4.6 Hz), 8.41 (1H, s); 
13C NMR (125 MHz, CDCl3) δ: 42.7 (q), 78.0 (s), 85.5 (d), 100.5 
(s), 111.0 (d), 115.2 (s), 131.1 (d), 142.8 (s), 150.5 (s), 150.6 (d); 
HRMS (FAB) calcd for C10H10N3O2S [M+H+]: 236.0494, found: 
236.0500. 
4.4.6. N-(6-Ethynyl-1H-pyrrolo[3,2-b]pyridin-7-yl)acetamide 
(25). To a stirred mixture of 24 (166 mg, 0.7 mmol) and DMAP 
(10 mg, 0.07 mmol) in dichloroethane (5 mL) were added Et3N 
(0.3 mL, 2.1 mmol) and Ac2O (0.33 mL, 3.5 mmol), then the 
mixture was stirred at 70 °C for 5 h under argon. After being 
cooled to room temperature, solvent was removed under reduced 
pressure and the residue was purified by column chromatography 
over silica gel with n-hexane–EtOAc (3:1) to give the 
corresponding bis-acetylated product (90 mg, 0.32 mmol). Then, 
a mixture of this compound and K2CO3 (45 mg, 0.32 mmol) in 
MeOH (2 mL) was stirred at room temperature for 5 min. The 
resulting mixture was purified by column chromatography over 
alumina with n-hexane–EtOAc (3:1) to give 25 (24 mg, 25% 
yield from 24) as a white solid: Rf = 0.40 (alumina, = n-
hexane/EtOAc 2/1); mp 167 °C; IR (neat) cm-1 3303 (NH), 2253 
(C≡C), 1729 (C=O); 1H NMR (500 MHz, CDCl3) δ: 2.37 (3H, s), 
3.64 (1H, s), 6.72 (1H, dd, J = 2.4, 2.4 Hz), 7.49 (1H, dd, J = 2.4, 
2.4 Hz), 8.26 (1H, br s), 8.48 (1H, s), 10.70 (1H, br s); 13C NMR 
(125 MHz, CDCl3) δ: 24.6 (q), 78.2 (s), 86.0 (d), 99.4 (s), 103.9 
(d), 117.6 (s), 129.0 (d), 130.9 (s), 146.5 (d), 148.8 (s), 169.0 (s); 
HRMS (FAB) calcd for C11H10N3O [M+H+]: 200.0824, found: 
200.0821. 
4.4.7. N-[6-Ethynyl-1-(methylsulfonyl)-1H-pyrrolo[3,2-
b]pyridin-7-yl]methanesulfonamide (26). A mixture of 24 (500 
mg, 2.1 mmol) and NaH (150 mg, 6.3 mmol) in THF (10 mL) 
was stirred at –20 °C for 30 min under argon. To the resulting 
mixture was added MsCl (0.45 mL, 6.3 mmol) and stirred at 
room temperature for an additional 2 h under argon. The reaction 
mixture was acidified by aqueous HCl (1 N) until pH < 2, then 
extracted with EtOAc. The organic layer was washed with brine, 
dried over MgSO4, and evaporated. The residue was purified by 
column chromatography over silica gel with n-hexane–EtOAc 
(2:1), then recrystallized from n-hexane–EtOAc (3:1) to give 26 
(348 mg, 53% yield) as colorless crystals: Rf = 0.65 (silica gel, n-
hexane/EtOAc = 1/2); mp 168 °C; IR (neat) cm-1 3223 (C≡C), 
1356, 1330, 1148, 1121 (SO2 × 2); 1H NMR (500 MHz, CDCl3) 
δ: 3.49 (1H, s), 3.59 (3H, s), 3.65 (3H, s), 6.94 (1H, d, J = 4.0 
Hz), 7.82 (1H, d, J = 4.0 Hz), 8.63 (1H, br s), 8.73 (1H, s); 13C 
NMR (125 MHz, CDCl3) δ: 44.1 (q), 44.5 (q), 80.6 (s), 84.4 (d), 
105.3 (s), 109.7 (d), 112.4 (s), 131.5 (s), 132.4 (d), 150.8 (s), 
152.3 (d); HRMS (FAB) calcd for C11H12N3O4S2 [M+H+]: 
314.0270, found: 314.0266. 
4.4.8. N-{6-[3-(Dipropylamino)prop-1-ynyl]-1H-pyrrolo[3,2-
b]pyridin-7-yl}acetamide (28). To a stirred mixture of 25 (24 mg, 
0.12 mmol), paraformaldehyde (8 mg, 0.24 mmol), CuCl (1.3 mg, 
0.012 mmol), Et3N (0.04 mL, 0.24 mmol) and MS4A (70 mg) in 
dioxane (1.5 mL) was added dipropylamine (0.02 mL, 0.12 
mmol), and the mixture was stirred for 5 h at 80 °C under argon. 
After being cooled to room temperature, the mixture was filtered 
through a pad of Celite. The filtrate was concentrated under 
reduced pressure and the residue was purified by column 
chromatography over alumina with n-hexane–EtOAc (4:1) to 
give 28 (16 mg, 42% yield) as a yellow solid: Rf = 0.50 (alumina, 
n-hexane/EtOAc = 2/1); mp 168 °C; IR (neat) cm-1 3259 (NH), 
2222 (C≡C), 1668 (C=O); 1H NMR (500 MHz, CDCl3) δ: 0.94 
(6H, t, J = 7.4 Hz), 1.50-1.58 (4H, m), 2.52 (4H, t, J = 7.4 Hz), 
2.36 (3H, s), 3.72 (2H, s), 6.79 (1H, d, J = 4.0 Hz), 7.62 (1H, d, J 
= 4.0 Hz), 8.36 (1H, s), 10.84 (1H, br s); 13C NMR (125 MHz, 
CDCl3) δ: 11.8 (2C, q), 20.6 (2C, t), 24.8 (q), 42.8 (t), 55.7 (2C, 
t), 78.4 (s), 93.1 (s), 101.8 (s), 110.7 (d), 115.2 (s), 130.6 (d), 
141.8 (s), 149.7 (s), 150.0 (d), 170.1 (s); HRMS (FAB) calcd for 
C18H25N4O [M+H+]: 313.2028, found: 313.2021. 
4.4.9. N-{[1,8-Bis(methylsulfonyl)-1,8-dihydrodipyrrolo[3,2-
b:2',3'-d]pyridin-7-yl]methyl}-N-propylpropan-1-amine (29) 
(Table 2, entry 3). To a stirred mixture of 26 (100 mg, 0.32 
mmol) and CuI (3 mg, 0.016 mmol) in dioxane (1 mL) was added 
a preheated solution (80 °C for 5 min) of paraformaldehyde (19 
mg, 0.64 mmol) and dipropylamine (0.044 mL, 0.32 mmol) in 
toluene (1 mL), and then the mixture was stirred at room 
temperature for 30 min under argon. Solvent was removed under 
reduced pressure and the residue was purified by column 
chromatography over alumina with n-hexane–EtOAc (2:1) to 
give 29 (95 mg, 70% yield) as a white solid: Rf = 0.70 (alumina, 
n-hexane/EtOAc = 1/1); mp 102 °C; IR (neat) cm-1 1361, 1296, 
1161, 1146 (SO2 × 2); 1H NMR (500 MHz, CDCl3) δ: 0.91 (6H, t, 
J = 7.4 Hz), 1.48-1.56 (4H, m), 2.44-2.48 (4H, m), 3.32 (3H, s), 
δ: 3.44 (1H, dd, J = 15.5, 6.9 Hz), 3.47 (1H, dd, J = 15.5, 6.9 Hz), 
3.82 (3H, s), 5.86 (1H, dd, J = 6.9, 6.9 Hz), 6.76 (1H, d, J = 4.0 
Hz), 7.81 (1H, d, J = 4.0 Hz), 8.50 (1H, s); 13C NMR (125 MHz, 
CDCl3) δ: 11.8 (2C, q), 20.3 (2C, t), 40.3 (q), 44.3 (q), 48.3 (t), 
56.1 (2C, t), 107.5 (d), 111.7 (d), 120.3 (s), 131.3 (s), 135.4 (s), 
142.8 (d), 145.6 (s), 151.2 (d), 152.0 (s); HRMS (FAB) calcd for 
C18H27N4O4S2 [M+H+]: 427.1474, found: 427.1466. 
4.4.10. 1,8-Bis(methylsulfonyl)-1,8-dihydrodipyrrolo[3,2-b:2',3'-
d]pyridine (30) (Table 2, entry 1). To a stirred mixture of 26 (50 
mg, 0.16 mmol) and CuI (1.5 mg, 0.008 mmol) in dioxane (1 
mL) were added paraformaldehyde (10 mg, 0.32 mmol) and 
dipropylamine (0.022 mL, 0.16 mmol), then the mixture was 
stirred at room temperature for 30 min under argon. The solvent 
was removed under reduced pressure and the residue was purified 
by column chromatography over alumina with n-hexane–EtOAc 
(3:1) to give 29 (20 mg, 30% yield) and 30 (15 mg, 29% yield). 
Compound 30: white solid; Rf = 0.45 (alumina, n-hexane/EtOAc 
= 1/1); mp 170 °C; IR (neat) cm-1 1363, 1320, 1165, 1108 (SO2 × 
2); 1H NMR (500 MHz, CDCl3) δ: 3.30 (3H, s), 3.82 (3H, s), 
5.11 (1H, d, J = 3.4 Hz), 5.34 (1H, d, J = 3.4 Hz), 6.77 (1H, d, J 
= 3.9 Hz), 7.83 (1H, d, J = 3.9 Hz), 8.57 (1H, s); 13C NMR (125 
MHz, CDCl3) δ: 49.5 (q), 53.8 (q), 105.7 (s), 117.2 (d), 119.4 (s), 
129.8 (s), 141.1 (d), 145.2 (s), 152.7 (d), 161.1 (d), 161.3 (s); 
HRMS (FAB) calcd for C11H12N3O4S2 [M+H+]: 314.0269, found: 
314.0257. 
4.4.11. N-{6-[3-(Dipropylamino)prop-1-ynyl]-1-(methylsulfonyl)-
1H-pyrrolo[3,2-b]pyridin-7-yl}methanesulfonamide (31). A 
solution of 29 (20 mg, 0.05 mmol) in CDCl3 (0.5 mL) was placed 
in a NMR tube. After 24 h at room temperature, 1H NMR 
analysis showed that 29 was converted to 31 with a ratio of 4:1 
(31/29). The mixture was purified by column chromatography 
over silica gel with CHCl3–MeOH (9:1) to give 31 (13 mg, 65% 
yield) as an orange oil; Rf = 0.50 (silica gel, CHCl3/MeOH = 
9/1); IR (neat) cm-1 2228 (C≡C), 1349, 1316, 1158, 1137 (SO2 × 
2); 1H NMR (500 MHz, CDCl3) δ: 0.94 (6H, t, J = 7.2 Hz), 1.52-
1.57 (4H, m), 2.59 (4H, t, J = 7.4 Hz), 3.51 (3H, s), 3.66 (3H, s), 
3.69 (2H, s), 6.88 (1H, d, J = 3.4 Hz), 7.78 (1H, d, J = 3.4 Hz), 
8.63 (1H, s); 13C NMR (125 MHz, CDCl3) δ: 11.8 (2C, q), 20.3 
(2C, t), 43.6 (q), 44.0 (q), 44.2 (t), 55.8 (2C, t), 82.4 (s), 92.0 (s), 
109.3 (d), 113.0 (s), 123.2 (s), 131.8 (d), 136.2 (s), 149.9 (s), 
152.0 (d); HRMS (FAB) calcd for C18H27N4O4S2 [M+H+]: 
427.1474, found: 427.1478. 
4.4.12. N-{6-[3-(Dipropylamino)prop-1-ynyl]-1H-pyrrolo[3,2-
b]pyridin-7-yl}methanesulfonamide (32) and 4-[2-
(dipropylamino)ethyl]-1,9-dihydropyrrolo[2',3':5,6]pyrido[4,3-
c][1,2]thiazine 2,2-dioxide (33). A mixture of 29 (94 mg, 0.22 
mmol) and Cs2CO3 (216 mg, 0.66 mmol) in THF (2 mL) and 
MeOH (1 mL) was stirred at 70 °C for 3 h under argon. After 
being cooled to room temperature, the solvent was removed 
under reduced pressure and the residue was purified by column 
chromatography over silica gel with CHCl3–MeOH (9:1) to give 
33 (43 mg, 52% yield) and 32 (9 mg, 12% yield). 
Compound 32: orange oil; Rf = 0.45 (silica gel, CHCl3/MeOH = 
9/1); IR (neat) cm-1 3440 (NH), 2249 (C≡C), 1342, 1159 (SO2); 
1H NMR (500 MHz, CDCl3) δ: 0.94 (6H, t, J = 7.4 Hz), 1.53-
1.58 (4H, m), 2.57-2.61 (4H, m), 3.13 (3H, s), 3.68 (2H, s), 6.48 
(1H, dd, J = 2.9, 2.9 Hz), 7.38 (1H, dd, J = 2.9, 2.9 Hz), 8.07 (1H, 
s), 10.49 (1H, br s); 13C NMR (125 MHz, CDCl3) δ: 11.9 (2C, q), 
20.2 (2C, t), 41.7 (q), 43.1 (t), 55.7 (2C, t), 79.6 (s), 90.6 (s), 
100.2 (s), 105.1 (d), 111.5 (s), 120.6 (s), 129.5 (d), 137.4 (s), 
141.5 (d); HRMS (FAB) calcd for C17H25N4O2S [M+H+]: 
349.1698, found: 349.1688. 
Compound 33: light yellow solid; Rf = 0.30 (silica gel, 
CHCl3/MeOH = 9/1); mp 205 °C; IR (neat) cm-1 3187 (NH), 
1409, 1104 (SO2); 1H NMR (500 MHz, DMSO-d6) δ: 0.84 (6H, t, 
J = 7.2 Hz), 1.36-1.44 (4H, m), 2.43 (4H, t, J = 7.4 Hz), 2.68 (2H, 
t, J = 7.2 Hz), 2.77 (2H, t, J = 7.2 Hz), 6.42 (1H, d, J = 2.9 Hz), 
6.49 (1H, s), 7.47 (1H, d, J = 2.9 Hz), 8.28 (1H, s), 12.26 (1H, br 
s); 13C NMR (125 MHz, DMSO-d6) δ: 11.7 (2C, q), 19.7 (2C, t), 
29.5 (t), 52.9 (t), 55.1 (2C, t), 96.4 (d), 105.7 (s), 117.1 (d), 121.7 
(s), 128.0 (d), 131.8 (s), 133.2 (d), 140.3 (s), 145.1 (s); HRMS 
(FAB) calcd for C17H25N4O2S [M+H+]: 349.1698, found: 
349.1688. 
4.4.13. N-(6-Ethynyl-1H-pyrrolo[3,2-b]pyridin-7-
yl)methanesulfonamide (36). A mixture of 26 (100 mg, 0.32 
mmol) and Cs2CO3 (214 mg, 0.64 mmol) in THF (2 mL) and 
MeOH (1 mL) was stirred at 50 °C for 3 h under argon. After 
being cooled to room temperature, solvent was removed under 
reduced pressure and the residue was purified by column 
chromatography over silica gel with CHCl3–MeOH (9:1) to give 
36 (61 mg, 82% yield) as a white solid: Rf = 0.40 (silica gel, 
CHCl3/MeOH = 9/1); mp 147 °C; IR (neat) cm-1 3282 (NH), 
3226 (C≡C), 1343, 1115 (SO2); 1H NMR (500 MHz, DMSO-d6) 
δ: 3.04 (3H, s), 4.13 (1H, s), 6.44 (1H, d, J = 3.0 Hz), 7.67 (1H, 
dd, J = 3.0, 3.0 Hz), 8.22 (1H, s), 11.16 (1H, s), 13.15 (1H, br s); 
13C NMR (125 MHz, DMSO-d6) δ: 42.1 (q), 79.6 (s), 83.7 (d), 
96.7 (s), 103.1 (s), 108.4 (d), 124.3 (s), 127.1 (d), 130.7 (s), 143.4 
(d); HRMS (FAB) calcd for C10H10N3O2S [M+H+]: 236.0494, 
found: 236.0500. 
4.4.14. N-{[8-(Methylsulfonyl)-1,8-dihydrodipyrrolo[3,2-b:2',3'-
d]pyridin-7-yl]methyl}-N-propylpropan-1-amine (37). To a 
stirred mixture of 36 (53 mg, 0.23 mmol) and CuI (2.6 mg, 0.012 
mmol) in dioxane (1 mL) was added a preheated solution (80 °C, 
5 min) of paraformaldehyde (14 mg, 0.46 mmol) and 
dipropylamine (0.032 mL, 0.23 mmol) in toluene (1 mL), and 
then the mixture was stirred at room temperature for 30 min 
under argon. The solvent was removed under reduced pressure 
and the residue was purified by column chromatography over 
alumina with n-hexane–EtOAc (5:1) to give 37 (50 mg, 65% 
yield) as a white solid: Rf = 0.65 (alumina, n-hexane/EtOAc = 
1/1); mp 125 °C; IR (neat) cm-1 3439 (NH), 1337, 1153 (SO2); 1H 
NMR (500 MHz, CDCl3) δ: 0.81 (6H, t, J = 7.2 Hz), 1.42-1.48 
(4H, m), 2.45-2.48 (4H, m), 3.60 (3H, s), 3.90 (2H, s), 6.71 (1H, 
s), 6.84-6.86 (1H, m), 7.35-7.37 (1H, m), 8.68 (1H, s), 9.95 (1H, 
s); 13C NMR (125 MHz, CDCl3) δ: 11.7 (2C, q), 18.7 (2C, t), 
42.1 (q), 52.0 (t), 54.8 (2C, t), 104.3 (d), 111.1 (d), 115.0 (s), 
119.3 (s), 124.8 (d), 127.4 (s), 136.0 (s), 137.4 (d), 143.9 (s); 
HRMS (FAB) calcd for C17H25N4O2S [M+H+]: 349.1698, found: 
349.1696. 
4.4.15. N-[(1,8-Dihydrodipyrrolo[3,2-b:2',3'-d]pyridin-7-
yl)methyl]-N-propylpropan-1-amine (27). A mixture of 37 (50 
mg, 0.14 mmol) and Cs2CO3 (91 mg, 0.28 mmol) in THF (1 mL) 
and MeOH (0.5 mL) was stirred at 55 °C for 1 h under argon. 
After being cooled to room temperature, solvent was removed 
under reduced pressure and the residue was purified by column 
chromatography over alumina with CHCl3–MeOH (30:1) to give 
27 (30 mg, 78% yield) as a yellow solid: Rf = 0.55 (alumina, 
CHCl3/MeOH = 15/1); IR (neat) cm-1 3431 (NH × 2); mp 155 °C 
(decomp.); 1H NMR (500 MHz, DMSO-d6) δ: 0.84 (6H, t, J = 7.4 
Hz), 1.43-1.51 (4H, m), 2.40 (4H, t, J = 7.4 Hz), 3.73 (2H, s), 
6.44 (1H, s), 6.54 (1H, dd, J = 2.5, 2.5 Hz), 7.34 (1H, dd, J = 2.5, 
2.5 Hz), 8.47 (1H, s), 10.50 (1H, s), 10.72 (1H, s); 13C NMR (125 
MHz, DMSO-d6) δ: 11.8 (2C, q), 19.6 (2C, t), 51.3 (t), 55.4 (2C, 
t), 100.5 (d), 102.7 (d), 115.2 (s), 120.1 (s), 123.1 (d), 126.7 (s), 
134.8 (s), 136.7 (d), 139.5 (s); HRMS (FAB) calcd for C16H23N4 
[M+H+]: 271.1922, found: 271.1924. 
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